24.6 C
Jalandhar
Wednesday, October 27, 2021

ਵਾਹਿਗੁਰੂ

spot_img
yes punjab punjabi redirection

Mera Ghar

Loan Waiver

Kisan Victims

Water Bills

Electricity Bills

Invest Punjab

Group D

Parali

PSSSB Chemical

Markfed Sept to Nov

Innocent

Antibodies from Covid’s original strain don’t bind to variants: Study

- Advertisement -
New York, Sep 18, 2021- People infected with the original strain of the SARS-CoV2 virus that caused Covid-19 early during the pandemic outbreak produced a consistent antibody response, making two main groups of antibodies to bind to the spike protein on the virus’s outer surface.

However, those antibodies don’t bind well to newer variants, finds a new study, published in the journal Nature Communications.

According to researcher Nicholas Wu from the University of Illinois at Urbana-Champaign, characterising what kinds of antibodies the body is most likely to make to fight a natural infection is an important roadmap for vaccine design.

For the study, the researchers mined published papers about Covid-19 patients for data about the sequence of the antibodies they produced.

They focused on antibodies against the spike protein, the part of the virus that binds to receptors on human cells to infect them. The spike protein is the target of most vaccines.

They found that many antibody sequences converged into two main groups, indicating a consistent human immune response to the virus.

“We really focused on characterising the antibodies created in those infected with the original strain of the virus,” said Timothy Tan, a graduate student part of the research.

“Before we started the study, variants weren’t much of a problem. As they emerged, we wanted to see whether the common antibodies we identified were able to bind to newer variants,” Tan added.

The researchers studied the convergent antibodies’ ability to bind to several variants and found that they no longer bound to some.

The finding has implications for the ability of new variants to reinfect people who contracted earlier versions of the virus, as well as for the continuing efficacy of vaccines and the design of possible vaccine boosters.

“Even though this antibody response is very common with the original strain, it doesn’t really interact with variants,” Wu said.

“That, of course, raises the concern of the virus evolving to escape the body’s main antibody response. Some antibodies should still be effective — the body makes antibodies to many parts of the virus, not only the spike protein — but the particular groups of antibodies that we saw in this study will not be as effective,” Wu added. (Agency)

Subscribe to YesPunjab Telegram Channel & receive important news updates

- Advertisement -

Yes Punjab - TOP STORIES

Punjab News

Sikh News

Transfers, Postings, Promotions

- Advertisement -spot_img

Stay Connected

20,369FansLike
112,682FollowersFollow

ENTERTAINMENT

National

GLOBAL

OPINION

Senior Citizen Saving

Is Senior Citizen Saving Scheme Tax-Free?

Do senior citizens have a saving scheme? If you are not aware of this, you are a little behind the game I would say....
UK Glasgow Climate Change Summit

Glasgow Climate Change Summit – by Asad Mirza

The upcoming Glasgow Summit will prove whether the global leaders are ready to put the entire mankind to peril or whether sagaciously they'll work...
Security Force in Kashmir

Kashmir: A battle that has been laid off for far too long- by Amjad Ayub Mirza

On October 22, 1947 Pakistan attacked the State of Jammu and Kashmir. It was the beginning of a conflict that would leave thousands dead...

SPORTS

Health & Fitness

Genes

Your genes may determine deeply held moral values

London, Oct 27, 2021- A person's disapproval of noncommittal sex and their condemnation of recreational drug use may have a common genetic basis, suggests a study. The research, published in the journal Psychological Science, showed that moral views concerning both recreational drugs and openness to non-committed sex are approximately 50 per cent heritable, with the remaining 50 per cent explained...

Gadgets & Tech